Future Heart Attack Treatments Will Use Light, Not Volts, to Keep Your Heart Beating

The Citizen's Guide to the Future
Aug. 30 2013 4:44 PM

Future Heart Attack Treatments Will Use Light, Not Volts, to Keep Your Heart Beating

130830_FT_heartbeat
In this illustration, the “optrode” at left delivers blue light to the heart via a fiber-optic tip. At right, a heart cell (large red oval) contains an implanted light-sensitive “opsin” protein (blue oval) that works alongside the heart’s own proteins (yellow ovals). This teamwork allows the cell to convert light energy into an electric kick that triggers a healthy heartbeat.

Graphic courtesy of Patrick M. Boyle

Electricity is as blunt a tool as we have in our medical arsenal. Whether it’s an implanted pacemaker or defibrillator paddles on the chest—CLEAR!—using electricity to kick-start a heart feels like getting kicked by a Clydesdale. We use it because it works, but we can’t stop all those volts from ripping through surrounding flesh and bone. Scientists call this a global electrical response, and it does a number on the human body, from killing cells to disrupting the heart’s normal rat-a-tat rhythm. And that’s why a team at Johns Hopkins University is experimenting with a lighter approach.

Literally. Through an emerging field called optogenetics, they plan to use a fancy blue light to coax the heart out of its funk.

Advertisement

“Wouldn’t it be amazing to shine a light on somebody who’s having a heart attack and you’re able to restore their life?” muses Natalia Trayanova, the Murray B. Sachs professor of biomedical engineering at Johns Hopkins University. “We’re far from that, but just the idea of that is really driving this research.”

It sounds fantastical—more like something out of Men in Black than modern medicine—but the study of optogenetics has already made great strides in neuroscience. Now, Trayanova and her team aim to expand the field to cardiology.

Here’s how it works. The scientists start by inserting light-responsive proteins, called opsins, into individual cells. When exposed to the proper intensity of blue light, the opsins react by opening gateways to the heart’s natural electrical impulses, thus jump-starting the rhythm. A defibrillator works in the same way, though instead of unlatching the gate politely, it charges through like Raiden on a combo.

Treating the heart with this method would also allow medical professionals to target specific areas in need of a low-energy jolt, instead of bathing the whole body in electrical bedlam.

Trayanova and her colleagues are currently testing opsins on an extremely sophisticated computer model of the heart in order to determine the most productive avenues to explore with live flesh. Not only does the model let them see how opsins might perform from the individual cell level on up to the heart as a whole, but in the future it could allow doctors to tailor optogenetic solutions for individual patients.

Since normal human heart cells don’t have opsins, optogenetics won’t be applicable for every patient who comes into an emergency room clutching his or her chest—and we’re likely still a decade away from having this as a treatment option. But for people with increased risk of heart disease or a history of heart attack, this technology has the potential to save lives and improve their quality. “It should be completely painless,” Trayanova told me. 

While there’s clearly a lot of work left to do, one thing is certain: As optogenetic heart treatments come closer to reality, you’re going to see a whole slew of headlines talking about lightsabers

Future Tense is a partnership of SlateNew America, and Arizona State University.

TODAY IN SLATE

History

Slate Plus Early Read: The Self-Made Man

The story of America’s most pliable, pernicious, irrepressible myth.

Rehtaeh Parsons Was the Most Famous Victim in Canada. Now, Journalists Can’t Even Say Her Name.

Mitt Romney May Be Weighing a 2016 Run. That Would Be a Big Mistake.

Amazing Photos From Hong Kong’s Umbrella Revolution

Transparent Is the Fall’s Only Great New Show

The XX Factor

Rehtaeh Parsons Was the Most Famous Victim in Canada

Now, journalists can't even say her name.

Doublex

Lena Dunham, the Book

More shtick than honesty in Not That Kind of Girl.

What a Juicy New Book About Diane Sawyer and Katie Couric Fails to Tell Us About the TV News Business

Does Your Child Have Sluggish Cognitive Tempo? Or Is That Just a Disorder Made Up to Scare You?

  News & Politics
History
Sept. 29 2014 11:45 PM The Self-Made Man The story of America’s most pliable, pernicious, irrepressible myth.
  Business
Moneybox
Sept. 29 2014 7:01 PM We May Never Know If Larry Ellison Flew a Fighter Jet Under the Golden Gate Bridge
  Life
Dear Prudence
Sept. 30 2014 6:00 AM Drive-By Bounty Prudie advises a woman whose boyfriend demands she flash truckers on the highway.
  Double X
Doublex
Sept. 29 2014 11:43 PM Lena Dunham, the Book More shtick than honesty in Not That Kind of Girl.
  Slate Plus
Slate Fare
Sept. 29 2014 8:45 AM Slate Isn’t Too Liberal, but … What readers said about the magazine’s bias and balance.
  Arts
Brow Beat
Sept. 29 2014 9:06 PM Paul Thomas Anderson’s Inherent Vice Looks Like a Comic Masterpiece
  Technology
Future Tense
Sept. 29 2014 11:56 PM Innovation Starvation, the Next Generation Humankind has lots of great ideas for the future. We need people to carry them out.
  Health & Science
Medical Examiner
Sept. 29 2014 11:32 PM The Daydream Disorder Is sluggish cognitive tempo a disease or disease mongering?
  Sports
Sports Nut
Sept. 28 2014 8:30 PM NFL Players Die Young. Or Maybe They Live Long Lives. Why it’s so hard to pin down the effects of football on players’ lives.